Epithelial Barrier Dysfunction and Disease

Introduction to Epithelial Barrier Function

The epithelial barrier theory explains how barrier dysfunction initiates and perpetuates chronic disease through a vicious cycle, including initial barrier disruption, microbial translocation, opportunistic pathogen colonization, immune activation, microbial dysbiosis, chronic subepithelial inflammation, and defective epithelial healing, as described by the American Academy of Allergy, Asthma, and Immunology 1

Initial barrier disruption occurs when genetic defects in barrier-related molecules or environmental exposures damage tight junctions at epithelial surfaces, leading to chronic inflammation and disease, according to the American College of Allergy, Asthma, and Immunology 1
Microbial translocation follows, with commensal bacteria moving from surface locations into interepithelial and subepithelial tissues, as reported by the American Academy of Allergy, Asthma, and Immunology 1
Opportunistic pathogen colonization develops, including Staphylococcus aureus, Moraxella, Haemophilus, and Pneumococcus, as described by the American College of Allergy, Asthma, and Immunology 1
Immune activation against both commensals and pathogens generates systemic type 2 inflammation in allergic diseases, according to the American Academy of Allergy, Asthma, and Immunology 1

The epithelium serves multiple critical roles that extend far beyond simple barrier function, including innate immune sensing and response, cytokine production, mucosal immunity coordination, water and ion transport, and microbiome regulation, as reported by the European Academy of Allergy and Clinical Immunology 2
Innate immune sensing and response: Epithelial cells detect environmental threats and secrete cytokines (IL-25, IL-33, thymic stromal lymphopoietin) that orchestrate immune responses, according to the American Academy of Allergy, Asthma, and Immunology 4

Genetic risk factors predispose epithelial cells to hyperreactivity, but environmental exposures are required to convert this susceptibility into chronic inflammation, as described by the American College of Allergy, Asthma, and Immunology 2
Polymorphisms in barrier-related genes (including those expressed in airway epithelium) increase asthma risk, according to the American Academy of Allergy, Asthma, and Immunology 2

The transition from sterile intrauterine environment to densely colonized postnatal state represents a critical period where epithelial barrier establishment determines lifelong disease susceptibility, as reported by the European Academy of Allergy and Clinical Immunology 6
The gut epithelium transforms from sterile in utero to environmentally exposed and bacteria-colonized after birth, according to the American Academy of Allergy, Asthma, and Immunology 6

Mucosal dendritic cells and macrophages maintain host defense while controlling inflammation through suppressive cytokines TGF-β and IL-10, as described by the American College of Allergy, Asthma, and Immunology 6
Oral tolerance depends on finely tuned cross-talk between antigen-presenting cells and T cells, plus epithelial barrier integrity, according to the American Academy of Allergy, Asthma, and Immunology 6

Epithelial barrier dysfunction has been demonstrated in multiple conditions, including asthma, allergic rhinitis, chronic rhinosinusitis, and inflammatory bowel disease, as reported by the American Academy of Allergy, Asthma, and Immunology 2
Asthma is associated with epithelial barrier dysfunction, according to the American College of Allergy, Asthma, and Immunology 2

In ARDS, intact epithelial barrier function with ability to actively transport fluid out of alveoli is a favorable prognostic indicator, while inability to concentrate protein in edema fluid during the first 12 hours (indicating impaired epithelial barrier integrity) predicts poor outcome, as described by the American Thoracic Society 8

Future research must define mechanisms through which genetic risk factors lead to loss of homeostasis and identify protective versus pathogenic environmental factors, according to the American Academy of Allergy, Asthma, and Immunology 2
Complex interactions between epithelial barrier and mucosal immunity remain poorly understood, as reported by the European Academy of Allergy and Clinical Immunology 2